Clinical & Diagnostic
In a significant stride towards enhancing healthcare diagnostics in the Asia-Pacific region, QIAGEN has recently garnered attention with the approval of it...
February 13, 2024 | Interaction
Gilead Sciences, Inc. and CymaBay Therapeutics, Inc. announced today a definitive agreement whereby Gilead will acquire CymaBay for $32.50 ...
February 13, 2024 | News
New partnership model leverages Aptar Digital Health’s capabilities to support the development and operation of new and existing digital health sol...
February 12, 2024 | News
BioAro Inc., a leading international biotechnology company, has partnered with Assured Diagnostics Inc. to make their cutting-edge Whole Genome Sequencing ...
February 12, 2024 | News
153Sm-DOTMP utilizes a cutting-edge chelating agent to deliver Samarium-153 radioisotope, offering potential advancements in bone cancer treatment....
February 08, 2024 | News
QIAGEN, a global leader in molecular diagnostics, proudly announces the approval of its QIAstat-Dx Meningitis/Encephalitis Panel by the Health Sciences Aut...
February 06, 2024 | News
QIAGEN launches QIAstat-Dx Gastrointestinal Panel 2 and Meningitis/Encephalitis Panel, joining the Respiratory SARS-CoV-2 Panel QIAstat-Dx s...
February 06, 2024 | News
DELFI Diagnostics, Inc., a developer of accessible blood-based tests that deliver a new way to enhance cancer detection, announced availability of the comp...
February 04, 2024 | News
Lung cancer has a significant health and economic impact in the region. It is the most prevalent cancer, accounting for about 1 million deaths per year, an...
February 04, 2024 | News
Genmab A/S (Nasdaq: GMAB) and Pfizer, Inc. (NYSE: PFE) have reported that the European Medicines Agency (EMA) has validated the marketing authorization app...
February 02, 2024 | News
Fast track is a process designed to facilitate development, and accelerate the review of drugs to treat serious or life-threatening conditions and fill an ...
February 02, 2024 | News
The value of the companion diagnostics market is predicted to expand to nearly US $14B by 2030, driven in part by the power of these tests to inform t...
February 01, 2024 | News
Treatment with VX-548 led to statistically significant improvement in pain compared to placebo as well as a clinically meaningful reduction in pain from ...
January 31, 2024 | News
Fresenius Kabi announced it has introduced Posaconazole Injection, a generic substitute for Noxafil®, for use in treating or preventing serious fungal ...
January 30, 2024 | News
Most Read
Bio Jobs
News